Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -1.34% vs -15.76% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 65.62% vs -11.11% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 4.22% vs -4.90% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -3.77% vs 2.42% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 17.26% vs -15.79% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -1.34% vs -15.76% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -54.31% vs -63.86% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 65.62% vs -11.11% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -8.25% vs -38.22% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.22% vs -4.90% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 2.00% vs -13.42% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -3.77% vs 2.42% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






